β Subunit coexpression and the α1 subunit domain I-II linker affect piperidine block of neuronal calcium channels

Journal of Neuroscience

Volumn 16, Issue 8, 1996, Pages 2430-2443

  Zamponi, Gerald W ^a   Soong, Tuck W ^a   Bourinet, Emmanuel ^a   Snutch, Terry P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

barium current; fomocaine; functional expression; local anesthetics; penfluridol; procaine; Xenopus oocytes

Indexed keywords

CALCIUM CHANNEL; DIETHYLCARBAMAZINE; FLECAINIDE; FOMOCAINE; LOCAL ANESTHETIC AGENT; PENFLURIDOL; PROCAINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; INTRACELLULAR RECORDING; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS;

EID: 0029881925     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-08-02430.1996     Document Type: Article

References (69)

1. Akaike N, Kostyuk PG, Osipchuk YV (1989) Dihydropyridine-sensitive low threshold calcium channels in isolated rat hypothalamic neurones. J Physiol (Lond) 412:181-91.
2. Bean BP, Cohen CJ, Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81:613-642.
3. Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofmann F, Home WA, Mori Y, Schwartz A, Snutch TP, Tanabe T, Tsien RW (1994) The naming of voltage-gated calcium channels. Neuron 13:505-506.
4. Braeunig B, Busch AE, Mutschler E, Wess J, Oelschlaeger H (1989) Antiarrhythmic activity of the local anaesthetic fomocaine and some of its analogues. Arzneim Forsch 39:1436-1439.
5. Butterworth JF, Strichartz GR (1990) Molecular mechanisms of local anesthesia: a review. Anesthesiology 72:711-734.
6. Cahalan MD, Aimers W (1979) Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin. Biophys J 27:39-56.
7. Camm AJ, Fozzard HA, Janse MJ, Lazzara R, Rosen MR, Schwartz PJ (for the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology) (1991) The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84:1831-1851.
8. Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effects of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406-412.
9. Castellano A, Wei X, Birnbaumer L, Perez-Reyes E (1993a) Cloning and expression of a third calcium channel β subunit. J Biol Chem 268:3450-3455.
10. Castellano A, Wei X, Birnbaumer L, Perez-Reyes E (1993b) Cloning and expression of a neuronal calcium channel β subunit. J Biol Chem 268:12359-12366.
11. 1C L-type calcium channel in Xenopus oocytes. FEBS Lett 44:87-90.
12. Chernoff DM, Strichartz GR (1990) Kinetics of local anaesthetic inhibition of neuronal sodium currents. Biophys J 58:69-81.
13. Clarkson CW, Hondeghem LM (1985) Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac channels in guinea pig ventricular myocardium. Circ Res 56:496-506.
14. Courtney KR (1975) Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA 968. J Pharmacol Exp Ther 195:225-236.
15. Czuczwar SJ, Gasior M, Janusz W, Kleinbrok Z (1992) Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology 31:1179-1183.
16. 2+ channel regulation by a conserved β subunit domain. Neuron 13:495-503.
17. 1 subunit of an ω-conotoxin-sensitive calcium channel. Proc Natl Acad Sci USA 89:5058-5062.
18. Enyeart JJ, Biagi BA, Mlinar B (1992) Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines. Mol Pharmacol 42:364-372.
19. Fujita Y, Mynlieff M, Dirksen RT, Kim M, Niidome T, Nakai J, Friedrich T, Iwabe N, Miyata T, Furuichi T, Furutama D, Mikoshiba K, Mori Y, Beam KG (1993) Primary structure and functional expression of the ω-conotoxin-sensitive N-type calcium channel from rabbit brain. Neuron 10:585-598.
20. Galizzi JP, Fosset M, Romey G, Laudron P, Lazdunski M (1986) Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors. Proc Natl Acad Sci USA 83:7513-7517.
21. Gelband H (1994) Diethylcarbamazine salt in the control of lymphatic nliarisis. Am J Trop Med Hyg 50:655-662.
22. Glossmann H, Striessnig J (1990) Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol 114:1-105.
23. Gouid RJ, Murphy KMM, Reynolds IJ, Snyder SH (1983) Antischizophrenic drugs of the diphenylbulylpiperidine type act as calcium channel antagonists. Proc Natl Acad Sci USA 80:5122-5125.
24. Grantham CJ, Main MJ, Cannell MB (1994) Fluspiriline block of N-type calcium current in NGF-differentiated PC12 cells. Br J Pharmacol 111:483-488.
25. Guo X, Castle N, Chernoflf D, Strichartz GR (1992) Comparative inhibition of voltage-gated cation channels by local anesthetics. Ann NY Acad Sci 256:181-199.
26. Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497-515.
27. Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472:373-398.
28. Im HK, Im WB, Tsuzuki K (1993) Selective block of transient Ca channel current in mouse neuroblastoma cells by U-88779E. J Pharmacol Exp Ther 265:529-535.
29. Johansen J, Kleinhaus AL (1985) Properties of action potentials carried by divalent cations in identified leech neurons. J Comp Physiol 157:491-497.
30. Kaczorowski GJ, Slaughter RS, Garcia ML (1994) Strategies to discover novel ion channel modulators. In: Ion channels in the cardiovascular system: function and dysfunction, (Spooner P, ed), pp 463-487. Armonk, NY: Futura.
31. King VF, Garcia ML, Shevell JL, Slaughter RS, Kaczorowski GJ (1989) Substituted diphenylburylpiperidines bind to a unique high affinity site on the L-type calcium channel. J Biol Chem 264:5633-5641.
32. 2+ channel. Nature 352:527-530.
33. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, Numa S (1989) Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 340:230-233.
34. Mori Y, Friedrich T, Kim M-S, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T, Numa S (1991) Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350:398-402.
35. Nishimura S, Takeshima H, Hofmann F, Flockerzi V, Imoto K (1993) Requirement of the calcium channel β subunit for functional conformation. FEBS Lett 324:283-286.
36. Olcese R, Quin N, Schneider T, Neely A, Wei X, Stefani E, Birnbaumer L (1994) The amino terminus of a calcium channel beta subunit sets rates of channel inactivation independently of the subunits effects on activation. Neuron 13:1421-1438.
37. Peters T, Wilffert B, Vanhoutte PM, van Zwieten PA (1991) Calcium channels in the brain as targets for the calcium-channel modulators used in the treatment of neurological disorders. J Cardiovasc Pharmacol 18[Suppl 8]:S1-S5.
38. 1-subunit. Nature 368:67-70.
39. Ritchie JM, Greengard P (1961) On the active structure of local anesthetics. J Pharmacol Exp Ther 133:241-245.
40. Sah DWY, Bean BP (1994) Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. Mol Pharmacol 45:84-92.
41. Sanchez-Chapula J (1988) Effects of bupivacaine on membrane currents of guinea pig ventricular myocytes. Eur J Pharmacol 156:303-308.
42. ca in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. Am J Physiol 257:H1773-H1781.
43. Seeman P, Lee T (1975) Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine receptors. Science 188:1217-1219.
44. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719.
45. Sheldon RS, Cannon NJ, Duff HJ (1987) A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels. Circ Res 61:492-497.
46. Soong TW, Stea A, Hodson CD, Dubel SJ, Vincent SR, Snutch TP (1993) Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 260:1133-1136.
47. 1 subunit. Neuropharmacology 32:1103-1116.
48. 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc Natl Acad Sci USA 91:10567-10580.
49. Stea A, Soong TW, Snutch TP (1995) Voltage-gated calcium channels. In: Handbook of receptors and channels: ligand- and voltage-gated ion channels (North RA, ed), pp 113-152. Boca Raton, FL: CRC.
50. Strichartz G (1973) The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol 62:37-57.
51. 3H]azidopine within the alpha-1 subunit. Proc Natl Acad Sci USA 88:10769-10773.
52. Striessnig J, Hering S, Berger W, Vatterall W, Glossmann H (1994) Calcium antagonist binding domains of L-type calcium channels. In: Ion channels in the cardiovascular system: function and dysfunction, (Spooner P, ed), pp 441-458. Armonk, NY: Futura.
53. Sugiyama K, Muteki T (1994) Local anesthetics depress the calcium current of rat sensory neurons in culture. Anesthesiology 80:1369-1378.
54. Takahashi K, Akaike N (1991) Calcium antagonist effects on low-threshold (T-type) calcium current in rat isolated hippocampal CA1-pyramidal neurons. J Pharmacol Exp Ther 256:169-175.
55. Tomlinson WJ, Stea A, Bourinet E, Charnet P, Nargeot J, Snutch TP (1993) Functional properties of a neuronal class C L-type channel. Neuropharmacology 32:1117-1126.
56. + channels in planar lipid bilayers. J Gen Physiol 92:747-765.
57. Watanabe T, Kalasz H, Yabana H, Kuniyasu A, Mershon J, Itagaki K, Vaghy PL, Naito K, Nakayama H, Schwartz A (1993) Azidobutryl clentiazem, a new photoactivable diltiazem analog, labels benzothiazepine binding sites in the α1 subunit of the skeletal muscle calcium channel. FEBS Lett 334:261-264.
58. Weidmann S (1955) The effect of calcium and local anesthetics on the electrical properties of Purkinje fibers. J Physiol (Lond) 129:568-582.
59. Williams ME, Feldman DH, McCue AF, Brenner R, Velicclebi G, Ellis SB, Harpold MM (1992a) Structure and functional expression of α1, α2, and β subunits of a novel human neuronal calcium channel subtype. Neuron 8:71-84.
60. Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S, Maroufi A, McCue AF, Velicelebi G, Ellis SB, Harpold M (1992b) Structure and functional expression of an ω-conotoxin-sensitive human N-type calcium channel. Science 257:389-395.
61. 1E calcium channel subtypes. J Biol Chem 269:22347-22357.
62. Wulf H, Goedicke J, Herzig S (1994) Functional interaction between local anaesthetics and calcium antagonists in guineapig myocardium: electrophysiological studies with bupivacaine and nifedipine. Br J Anaesthesiol 73:364-370.
63. 2+ channels in guinea pig atrial cells. J Pharmacol Exp Ther 268:1135-1142.
64. Yamashita T, Nakajima T, Hamada E, Hazam H, Omata M, Kurachi Y (1995) Flecainide inhibits the transient outward current in atrial myocytes isolated from the rabbit heart. J Pharmacol Exp Ther 274:315-321.
65. Zamponi GW, French RJ (1993) Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle. Biophys J 65:2335-2347.
66. Zamponi GW, French RJ (1994) Amine blockers of the cytoplasmic mouth of sodium channels. A small structural change abolishes voltage dependence. Biophys J 67:1015-1027.
67. Zamponi GW, Doyle DD, French RJ (1993a) Fast lidocaine block of cardiac and skeletal muscle sodium channels. One site with two routes of access. Biophys J 65:80-90.
68. Zamponi GW, Doyle DD, French RJ (1993b) State-dependent block underlies the tissue specificity of lidocaine action on BTX-activated cardiac sodium channels. Biophys J 65:91-100.
69. Zamponi GW, Sui X, Codding PW, French RJ (1993c) Dual procainamide action on batrachotoxin-activated cardiac sodium channels: open channel block and prevention of inactivation. Biophys J 65:2324-2334.